Results
-
DNA from related UK Biobank participants has revealed genes that affect us differently depending on which parent we inherit them from.
-
UK Biobank data shows that opioid medications increase the likelihood of developing lung, pancreatic and bladder cancer – the same cancer types previously only linked to opium use
-
Data from more than 2 million people, including UK Biobank participants, casts doubt on the belief that a drink a day is good for brain health.
-
A condition that makes blood sugar appear falsely low can cause years‑long delays in type 2 diabetes diagnoses, UK Biobank data has revealed.
-
Genetic information from healthy UK Biobank participants provides insight into an understudied disorder – and reveals a puzzle piece that could help to find treatments.
-
Polygenic risk scores calculate how our genetic makeup shapes our likelihood of developing conditions ranging from heart disease to cancer. Research powered by UK Biobank’s vast amount of genetic data is revealing their promise for personalised healthcare – and their limitations.
-
DNA from nearly 750,000 people, including UK Biobank participants, reveals genes that make people prone to persistent Epstein-Barr virus infections, which are linked to rheumatoid arthritis, cancer and many other diseases.
-
There should be more focus on finding treatments that target the ‘Alzheimer’s gene’, researchers argue.
-
UK Biobank participants’ genetic data and questionnaire answers reveal some of the biological underpinnings of pain – raising hope of new therapies for the billions of people who experience persistent pain.
-
More awareness of Alexander disease, a progressive and disabling brain condition, could stop misdiagnoses and missed treatment opportunities.